Can wound blush be used as an indicator for termination of endovascular procedures in chronic limb-threatening ischemia patients?

被引:0
|
作者
Shahat, Mohammed [1 ]
Taha, Ashraf G. [1 ]
Elnaggar, Ashraf [1 ]
Aboloyoun, Hesham [1 ]
机构
[1] Assiut Univ Hosp, Dept Vasc & Endovascular Surg, Assiut, Egypt
关键词
Wound blush; chronic limb-threatening ischemia; amputation-free survival; limb-based patency; angiosomal revascularization; ANGIOSOME REVASCULARIZATION; BYPASS-SURGERY; FOOT; DISEASE; PERFUSION; OUTCOMES; SINGLE; VESSEL; IMPACT; GRADE;
D O I
10.1177/17085381241283096
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction Predicting the outcomes of endovascular revascularization of chronic limb-threatening ischemia (CLTI) patients with foot wounds can be challenging. Angiographic wound blush (WB) assessment has been found to be a helpful tool to assess wound perfusion. The aim of this study is to evaluate WB during endovascular revascularization of CLTI patients and its effects on treatment outcomes.Methods This prospective study included all CLTI patients with foot wounds who underwent successful endovascular revascularization of infrainguinal arterial disease between 2019 and 2021. Patients were grouped according to the WB status into positive WB (group A) and negative WB (group B). Both groups were compared for demographics, comorbidities, clinical picture, and 12-month limb-based patency (LBP) and amputation-free survival (AFS) rates.Results The study included 69 patients of Rutherford classes 5 (46.4%) and 6 (53.6%), with the main arterial lesion located at the femoropopliteal (58%) or infrapopliteal (42%) segments. Completion angiography showed positive WB in 38 (55.1%) patients and negative WB in 31 (44.9%) patients. Both groups were comparable regarding patient presentation, site of the main arterial lesion, and distribution of foot lesions in relation to the feeding artery. The overall 12-month LBP and AFS rates were 21.7% and 39.1%, respectively, with significantly better rates in group A than in group B (LBP, 31.6% vs 9.7%, p = 0.001 and AFS, 54.1% vs 22.2%, p = 0.006, respectively). Successful angiosome-based direct flow to the foot was achieved in 38 patients (55.1%), resulting in significantly better 12-month AFS rates than those with indirect revascularization (54.8% vs 26.3%, p = 0.036, respectively), despite the comparable 12-LBP rates between the direct and indirect revascularization groups (29% vs 15.8%, p = 0.133, respectively). Multivariate logistic regression analysis identified smoking as a significant predictor of a major amputation, whereas positive WB and successful direct revascularization were significant predictors of limb salvage.Conclusions WB can serve as a predictor for AFS and LBP during endovascular revascularization of CLTI patients with foot wounds. A positive WB may guide the decision to conclude an endovascular procedure, potentially avoiding unnecessary complicated maneuvers to recanalize more vessels. Conversely, a negative WB may suggest the need for further revascularization attempts to augment wound perfusion and healing.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Association of wound, ischemia, and foot infection clinical stage with frailty and malnutrition in chronic limb-threatening ischemia patients undergoing endovascular intervention
    Otsuji, Hideaki
    Kanda, Daisuke
    Takumi, Takuro
    Tokushige, Akihiro
    Sonoda, Takeshi
    Arikawa, Ryo
    Anzaki, Kazuhiro
    Ikeda, Yoshiyuki
    Ohishi, Mitsuru
    VASCULAR, 2023, 31 (03) : 504 - 512
  • [22] Advances in chronic limb-threatening ischemia
    Hammad, Tarek A.
    Shishehbor, Mehdi H.
    VASCULAR MEDICINE, 2021, 26 (02) : 126 - 130
  • [23] Predictors of Wound Healing Following Revascularization for Chronic Limb-Threatening Ischemia
    Antonopoulos, Constantine N.
    Lazaris, Andreas
    Venermo, Maarit
    Geroulakos, George
    VASCULAR AND ENDOVASCULAR SURGERY, 2019, 53 (08) : 649 - 657
  • [24] Features of asymptomatic contralateral limb in patients with chronic limb-threatening ischemia
    Takahara, Mitsuyoshi
    Iida, Osamu
    Soga, Yoshimitsu
    Kodama, Akio
    Terashi, Hiroto
    Azuma, Nobuyoshi
    JOURNAL OF CARDIOLOGY, 2022, 79 (01) : 153 - 160
  • [25] Appropriateness of Endovascular Therapy in Chronic Limb-Threatening Ischemia Patients Based on the Global Vascular Guidelines
    Dayama, Anand
    Panneton, Jean M.
    JOURNAL OF ENDOVASCULAR THERAPY, 2020, 27 (04) : 614 - 615
  • [26] Predictors of outcome in diabetic patients undergoing infrapopliteal endovascular revascularization for chronic limb-threatening ischemia
    Yap, Trixie
    Silickas, Justinas
    Weerakkody, Ruwan
    Lea, Talia
    Santhirakumaran, Gowthanan
    Bremner, Laura
    Diamantopoulos, Athanasios
    Biasi, Lukla
    Thomas, Stephen
    Zayed, Hany
    Patel, Sanjay D.
    JOURNAL OF VASCULAR SURGERY, 2022, 75 (02) : 618 - 624
  • [27] Bypass with Prosthetic Graft Is Superior to Endovascular Therapy in Diabetic Patients with Chronic Limb-threatening Ischemia
    Zarrintan, Sina
    Powell, Jenna
    Chaar, Cassius Iyad Ochoa
    Malas, Mahmoud
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E295 - E296
  • [28] The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia
    Santosa, Yudistira
    Harca, Azizah Dhena
    Sukmaja, Edwin
    Yuwono, Angelina
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [29] Complex Multilevel and Multivessel Endovascular Revascularization in a Patient With Chronic Limb-threatening Ischemia
    Alvarez, Alberto Martin
    del Pilar Lamarca Mendoza, Maria
    Peinado Cebrian, Francisco Javier
    Hernandez, Maite Arriola
    Seco, Santiago Estebanez
    Herrero, Angel Flores
    Perez-Grueso, Antonio Orgaz
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (04) : 34S - 34S
  • [30] The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis
    Matsuda, Yoshihiro
    Miyake, Tomoko
    Toda, Hironobu
    Tachibana, Kota
    Nomura, Hayato
    Hirai, Yoji
    Kawakami, Yoshio
    Sakoda, Naoya
    Morizane, Shin
    JOURNAL OF DERMATOLOGY, 2024, 51 (08): : 1108 - 1112